PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lübeck Institute of Experimental Dermatology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany. dr_kridin@hotmail.com.\', \'Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel. dr_kridin@hotmail.com.\', \'Unit of Dermatology and Skin Research Laboratory, Baruch Padeh Medical Center, Poriya, Israel. dr_kridin@hotmail.com.\', \'Clalit Health Services, Tel-Aviv, Israel.\', \'Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.\', \'Baruch Padeh Medical Center, Poriya, Tiberias, Israel.\', \'Department of Behavioral Sciences, Ariel University, Ariel, Israel.\', \'Faculty of Health Sciences, Ben-Gurion University of the Negev, Ben-Gurion Ave, Beer Sheva, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s12026-021-09234-z
?:hasPublicationType
?:journal
  • Immunologic research
is ?:pmid of
?:pmid
?:pmid
  • 34647194
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.198
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment-a population-based cohort study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all